ALT, alanine transaminase
Cosadioate, Olive Oil, Jojoba Seed Oil, Stearoyl Inulin, Lavender Oil, Lemon Peel Oil, Citrus Aurantium Dulcis Fruit Oil, Polyglyceryl-10 Behenate/Eicosadioate, Citrus Aurantium Dulcis Peel Oil, Atlas Cedrus Wood Oil, Caprylyl Glycol, Ethylhexylglycerin, Orange Peel Oil, Rosemary Leaf Oil, Purified Water, Candida Bombicola/Glucose/Methyl Rapeseedate Ferment, Tocopherol, 1,2-Hexanediol, Ascorbic Acid (500,1 PPD), Hydroxypropyl Cyclodextrin, Glutathione (30 ppb), Disodium EDTA, Niacinamide, Pantothenic Acid, Linolenic Acid, Biotin, Tocopheryl Acetate, Cyanocobalamin, Limonene, Linalool
S., Cali, A
10.1074/jbc.M113.467670 200
The peptide is a disulfide-cyclized octamer and is reported to have agonist activity on both hMC3R (EC 50 = 1.61 nM, E max = 84%) and hMC4R (EC 50 = 0.280 nM, E max = 95%) as shown in Table 1 ( 50 = 4.2 nM, E max = 91%) and demonstrates enhanced hMC4R potency (EC 50 = 0.048 nM, E max = 100%) ( A phase I clinical trial to assess the safety of LY2112688 was conducted in the mid-late 2000s ( Table 2 )
This is the most frequently reported side effect, especially with DAC
